DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Ben Tallon, Dermatologist/Dermatopathologist, Tauranga, New Zealand, 2010.
Within the group of cutaneous B cell lymphomas, further categorisation includes primary cutaneous diffuse large B cell lymphoma, leg type; primary cutaneous diffuse large B cell lymphoma, other; plasmablastic lymphoma and T cell-rich large B cell lymphoma. The primary cutaneous B cell lymphoma leg type indicates a poor prognostic group typically seen on the lower legs of the elderly and is illustrated in the figures below.
Scanning power view of the histology of primary cutaneous diffuse large B cell lymphoma is of a dense superficial and deep cellular infiltrate (figure 1). Higher power identifies a dense atypical lymphocytic proliferation, which frequently extends into the subcutaneous tissue (figures 2, 3, 4, 5). Areas of crush artefact are common, and while not specific may be a clue to a malignant lymphoid population (figures 2, 3). The lymphocytes are large centroblast-like and immunoblast-like cells with non-cleaved nuclei and prominent nucleoli (figure 6, 7).
Primary cutaneous diffuse large B cell lymphoma pathology
Immunostaining reveals a CD20 positive B (figure 8) cell population with diffuse BCL2 (figure 9) and MUM1 staining. BCL6 expression is variable while CD10 is negative.
Primary cutaneous diffuse large B cell lymphoma – immunostaining
Primary cutaneous diffuse large B cell lymphoma, other, refers to those cases where the clinical features, histology and immunohistochemistry do not fit with primary cutaneous diffuse large B cell lymphoma, leg type, while also not consistent with a diagnosis of primary cutaneous follicle centre lymphoma.
See the DermNet NZ bookstore
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.